Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) Captisol®
licensee Lundbeck LLC today announced that the U.S. Food and Drug
Administration (FDA) has accepted for review a New Drug Application
(NDA) for its investigational...
By Small Pharma Analyst:
Although the stock price of Ligand Pharmaceuticals has soared nearly 4-fold over the past year, the anticipated rapid EPS growth over the next 3 years, with limited downside risk, makes this...
By Chris Katje:
· Ligand Pharmaceuticals has 85 fully funded programs in trials
· Recently approved Duavive could provide upside to 2014 guidance
· Strong gross margins and low share count provides huge profits for...
By Markus Aarnio:
In this article, I will feature one healthcare stock that has seen intensive insider selling during the last 30 days. Intensive insider selling can be defined by the following three criteria:
The stock was sold by three or...
In a report published Thursday, MLV & Co analyst Graig C. Suvannavejh reiterated a Buy rating on Ligand Pharmaceuticals (NASDAQ: LGND), and raised the price target from $82.00 to $96.00.
In the report, MLV & Co noted, “Yesterday, LGND...
Ligand Pharmaceuticals Incorporated (LGND)
Q4 2013 Earnings Conference Call
February 11, 2014 9:00 am ET
John Higgins - President and Chief Executive Officer
John Sharp - Vice President, Finance and Chief Financial...
LAVAL, QUEBEC -- (Marketwired) -- 02/06/14 -- ProMetic Life Sciences Inc. (TSX:PLI)(OTCQX:PFSCF), ("ProMetic" or the "Corporation") announced today that its UK based subsidiary, ProMetic BioSciences Ltd. ("PBL"), has entered into a new agreement...
An analyst at Roth Capital, Joseph Pantginis, earlier noted Ligand (NASDAQ: LGND) may see EPS growth of up to $0.35 over the next few years, as a result of “meaningful” royalty income from Promacta(R).
The product is used to treat persons...
Oops! Unable to complete your request. Please refresh your browser.
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.
You may also be interested in articles related to Ligand Pharmaceuticals (LGND):